Vanni Bucci
Has grant
Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Professor Vanni Bucci is a faculty member at the University of Massachusetts Medical School, USA. His research predominantly focuses on microbiology, specifically the development and application of narrow-spectrum antibiotics, the interplay between gut microbiota and various diseases, and the utilization of AI in disease detection and microbiome data integration. His recent publications include significant studies on microcins and their effects on pathogens, as well as on the health implications of microbiota in conditions such as Alzheimer's disease and inflammatory bowel disease.
Recent Grants
Grant: Open
Aging Microbiome, Immunosenescence, and risk of Multi-drug Resistant Organism Colonization and Infection in the Nursing Home
Open Date: 2023-02-15
Close Date: 2027-11-30
Grant: Open
Development of targeted microbiome therapeutics and dietary interventions for potent intestinal barrier promotion to minimize GI-ARS
Open Date: 2022-12-22
Close Date: 2027-11-30
Grant: Close
Mathematical Modeling and Synthetic Biology to Discover New ESBL-PE-Eradicating Microbiome-Based Therapeutics
Open Date: 2020-08-01
Close Date: 2023-07-31
Grant: Close
ABI Innovation: A new computational framework for the prediction of microbiome dynamics
Open Date: 2015-09-01
Close Date: 2018-08-31
Grant: Close
Mathematical modeling from metagenomics - minimizing risk of enteric infections
Open Date: 2015-02-05
Close Date: 2018-01-31
Articles (9)
Year:
2025
Year:
2025
Year:
2024
Year:
2024
SARS-CoV-2-positive patients exhibit gut and oral microbiome dysbiosis, which is associated with various aspects of COVID-19 disease (1–4). Here, we aim to identify gut and oral microbiome markers that predict COVID-19 severity in hospitalized patients, specifically severely ill patients compared to moderately ill ones. Moreover, we investigate whether hospital feeding (solid versus enteral), an important cofounder, influences the microbial composition of hospitalized COVID-19 patients. We used random forest classification machine learning models with interpretable secondary analyses. The gut, but not the oral microbiota, was a robust predictor of both COVID-19-related fatality and severity of hospitalized patients, with a higher predictive value than most clinical variables. In addition, perturbations of the gut microbiota due to enteral feeding did not associate with species that were predictive of COVID-19 severity. IMPORTANCE SARS-CoV-2 infection leads to wide-ranging, systemic symptoms with sometimes unpredictable morbidity and mortality. It is increasingly clear that the human microbiome plays an important role in how individuals respond to viral infections. Our study adds to important literature about the associations of gut microbiota and severe COVID-19 illness during the early phase of the pandemic before the availability of vaccines. Increased understanding of the interplay between microbiota and SARS-CoV-2 may lead to innovations in diagnostics, therapies, and clinical predictions.
Year:
2023
Year:
2022
Year:
2022
Year:
2020
Year:
2020
Collaborators (6)
John Haran
Professor
University of Massachusetts Chan Medical School
Jacob Palmer
Assistant Professor
Binghamton University
Ana Maldonado-Contreras
University of Massachusetts Chan Medical School
Barbara Olendzki
Associate Professor
UMass Medical School
Roozbeh Sadeghian
Harrisburg University of Science and Technology
Mark Silby
Associate Professor
University of Massachusetts Dartmouth
Make your next move.
Prepare your application
Review drafts before you send them.